Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Sex-related differences in mast cell activity and doxorubicin toxicity: a study in spontaneously hypertensive rats.

Zhang J, Knapton A, Lipshultz SE, Cochran TR, Hiraragi H, Herman EH.

Toxicol Pathol. 2014;42(2):361-75. doi: 10.1177/0192623313482778. Epub 2013 Mar 26.

PMID:
23531790
2.

Phosphorous dysregulation induced by MEK small molecule inhibitors in the rat involves blockade of FGF-23 signaling in the kidney.

Diaz D, Allamneni K, Tarrant JM, Lewin-Koh SC, Pai R, Dhawan P, Cain GR, Kozlowski C, Hiraragi H, La N, Hartley DP, Ding X, Dean BJ, Bheddah S, Dambach DM.

Toxicol Sci. 2012 Jan;125(1):187-95. doi: 10.1093/toxsci/kfr263. Epub 2011 Oct 5.

PMID:
21976371
3.

A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.

Stefanich EG, Danilenko DM, Wang H, O'Byrne S, Erickson R, Gelzleichter T, Hiraragi H, Chiu H, Ivelja S, Jeet S, Gadkari S, Hwang O, Fuh F, Looney C, Howell K, Albert V, Balazs M, Refino C, Fong S, Iyer S, Williams M.

Br J Pharmacol. 2011 Apr;162(8):1855-70. doi: 10.1111/j.1476-5381.2011.01205.x.

4.

Engineered thio-trastuzumab-DM1 conjugate with an improved therapeutic index to target human epidermal growth factor receptor 2-positive breast cancer.

Junutula JR, Flagella KM, Graham RA, Parsons KL, Ha E, Raab H, Bhakta S, Nguyen T, Dugger DL, Li G, Mai E, Lewis Phillips GD, Hiraragi H, Fuji RN, Tibbitts J, Vandlen R, Spencer SD, Scheller RH, Polakis P, Sliwkowski MX.

Clin Cancer Res. 2010 Oct 1;16(19):4769-78. doi: 10.1158/1078-0432.CCR-10-0987. Epub 2010 Aug 30.

5.

Human T-lymphotropic virus type-1 p30 alters cell cycle G2 regulation of T lymphocytes to enhance cell survival.

Datta A, Silverman L, Phipps AJ, Hiraragi H, Ratner L, Lairmore MD.

Retrovirology. 2007 Jul 16;4:49.

6.

Histone acetyltransferase (HAT) activity of p300 modulates human T lymphotropic virus type 1 p30II-mediated repression of LTR transcriptional activity.

Michael B, Nair AM, Datta A, Hiraragi H, Ratner L, Lairmore MD.

Virology. 2006 Oct 25;354(2):225-39. Epub 2006 Aug 4.

7.

Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13(II) is required for viral infectivity in vivo.

Hiraragi H, Kim SJ, Phipps AJ, Silic-Benussi M, Ciminale V, Ratner L, Green PL, Lairmore MD.

J Virol. 2006 Apr;80(7):3469-76.

8.

Human T-lymphotropic virus type 1 mitochondrion-localizing protein p13II sensitizes Jurkat T cells to Ras-mediated apoptosis.

Hiraragi H, Michael B, Nair A, Silic-Benussi M, Ciminale V, Lairmore M.

J Virol. 2005 Aug;79(15):9449-57.

9.

Human T lymphotropic virus type 1 accessory protein p12I modulates calcium-mediated cellular gene expression and enhances p300 expression in T lymphocytes.

Nair A, Michael B, Hiraragi H, Fernandez S, Feuer G, Boris-Lawrie K, Lairmore M.

AIDS Res Hum Retroviruses. 2005 Apr;21(4):273-84.

10.

The human T-cell leukemia virus type 1 p13II protein: effects on mitochondrial function and cell growth.

D'Agostino DM, Silic-Benussi M, Hiraragi H, Lairmore MD, Ciminale V.

Cell Death Differ. 2005 Aug;12 Suppl 1:905-15. Review.

11.

Human T lymphotropic virus type-1 p30II alters cellular gene expression to selectively enhance signaling pathways that activate T lymphocytes.

Michael B, Nair AM, Hiraragi H, Shen L, Feuer G, Boris-Lawrie K, Lairmore MD.

Retrovirology. 2004 Nov 23;1:39.

12.

Suppression of tumor growth and cell proliferation by p13II, a mitochondrial protein of human T cell leukemia virus type 1.

Silic-Benussi M, Cavallari I, Zorzan T, Rossi E, Hiraragi H, Rosato A, Horie K, Saggioro D, Lairmore MD, Willems L, Chieco-Bianchi L, D'Agostino DM, Ciminale V.

Proc Natl Acad Sci U S A. 2004 Apr 27;101(17):6629-34. Epub 2004 Apr 20.

13.

Analysis of gene transfer and expression in skeletal muscle using enhanced EIAV lentivirus vectors.

O'Rourke JP, Hiraragi H, Urban K, Patel M, Olsen JC, Bunnell BA.

Mol Ther. 2003 May;7(5 Pt 1):632-9.

14.

Glycogen branching enzyme deficiency in quarter horse foals.

Valberg SJ, Ward TL, Rush B, Kinde H, Hiraragi H, Nahey D, Fyfe J, Mickelson JR.

J Vet Intern Med. 2001 Nov-Dec;15(6):572-80.

Supplemental Content

Loading ...
Support Center